Literature DB >> 28483312

Current Knowledge and Management of Hypersensitivity to Perioperative Drugs and Radiocontrast Media.

Karen S Hsu Blatman1, David L Hepner2.   

Abstract

Perioperative anaphylaxis is an iatrogenic clinical condition, most often after anesthetic induction. Several mechanisms are implicated, including IgE- and non-IgE-mediated mechanisms. Perioperative anaphylaxis tends to be severe and has a higher mortality rate than anaphylaxis in other settings. This is partly due to factors that impair early recognition of anaphylaxis. Neuromuscular blocking agents, latex containing products, and antibiotics are the most common etiology. Chlorhexidine and dyes are increasingly culprits. The newest emerging cause is sugammadex, which is used for reversal of the effects of steroidal neuromusclar agents, such as rocuronium. Latex-induced allergy is becoming less common than in the 1980s due to primary and secondary prevention measures. Serum tryptase levels during the time of anaphylaxis and skin testing to suspected agents as an outpatient are necessary to confirm the diagnosis. Management includes epinephrine and aggressive fluid therapy. With radiocontrast media allergy, patients with a history of immediate hypersensitivity reactions to radiocontrast media should receive steroid and antihistamine premedication before re-exposure. Because IgE-mediated anaphylaxis to radiocontrast media is rare, there is a universal consensus that routinely skin testing all patients with a past reaction is not effective.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Anesthesia; Antibiotics; Beta-lactam; Cephalosporin; Chlorhexidine; Gadolinium; Latex; Neuromuscular blocking agents; Perioperative; Radiocontrast media; Skin test; Tryptase

Mesh:

Substances:

Year:  2017        PMID: 28483312     DOI: 10.1016/j.jaip.2017.03.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  6 in total

Review 1.  Approach to Perioperative Anaphylaxis in 2020: Updates in Diagnosis and Management.

Authors:  Jerry Kalangara; Kristine Vanijcharoenkarn; Grant C Lynde; Nichole McIntosh; Merin Kuruvilla
Journal:  Curr Allergy Asthma Rep       Date:  2021-01-06       Impact factor: 4.806

Review 2.  Fatal Anaphylaxis: Epidemiology and Risk Factors.

Authors:  Irene Mikhail; David R Stukus; Benjamin T Prince
Journal:  Curr Allergy Asthma Rep       Date:  2021-04-07       Impact factor: 4.806

3.  Incidence, etiology, predictors and outcomes of suspected drug hypersensitivity reactions in a tertiary care university hospital's emergency department : A retrospective study.

Authors:  Cvijeta Bielen; Luka Bielen; Robert Likić
Journal:  Wien Klin Wochenschr       Date:  2019-04-29       Impact factor: 2.275

4.  Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report.

Authors:  Shu Chung Choi; Sangbin Han; Jueun Kwak; Ji Yung Lee
Journal:  Korean J Anesthesiol       Date:  2019-10-17

5.  What do we know about perioperative hypersensitivity reactions and what can we do to improve perioperative safety?

Authors:  Urszula Kosciuczuk; Pawel Knapp
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

6.  Pediatric drug hypersensitivity: which diagnostic tests?

Authors:  Francesca Saretta; Francesca Mori; Fabio Cardinale; Lucia Liotti; Fabrizio Franceschini; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau; Roberto Bernardini; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.